Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Weener HJ"'
Autor:
Alb M; Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg, Würzburg, Germany., Reiche K; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany., Rade M; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany., Sewald K; Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM, Hannover, Germany., Loskill P; Institute for Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.; 3R-Center for In vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen.; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Cipriano M; Institute for Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.; 3R-Center for In vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen., Maulana TI; Institute for Biomedical Engineering, Eberhard Karls University Tübingen, Tübingen, Germany.; 3R-Center for In vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen., van der Meer AD; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., Weener HJ; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., Clerbaux LA; European Commission, Joint Research Centre (JRC), Ispra, Italy., Fogal B; Department on Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceutical, Inc, Ridgefield, CT, USA., Patel N; Preclinical Safety, Research and Development, Sanofi-Aventis US, LLC, Cambridge, MA, USA., Adkins K; Preclinical Safety, Research and Development, Sanofi-Aventis US, LLC, Cambridge, MA, USA., Lund E; Labcorp Drug Development Inc, Derbyshire, UK., Perkins E; Labcorp Drug Development Inc, Derbyshire, UK., Cooper C; Labcorp Drug Development Inc, Derbyshire, UK., van den Brulle J; T-CURX GmbH, Würzburg, Germany., Morgan H; Novartis Biomedical Research, Novartis Campus, Basel, Switzerland., Rubic-Schneider T; Novartis Biomedical Research, Novartis Campus, Basel, Switzerland., Ling H; Novartis Biomedical Research, Cambridge, MA, USA., DiPetrillo K; Novartis Biomedical Research, Cambridge, MA, USA., Moggs J; Novartis Biomedical Research, Novartis Campus, Basel, Switzerland., Köhl U; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany., Hudecek M; Medizinische Klinik und Poliklinik II, Lehrstuhl für Zelluläre Immuntherapie, Universitätsklinikum Würzburg, Würzburg, Germany.; Fraunhofer-Institut für Zelltherapie und Immunologie IZI, Leipzig, Germany.
Publikováno v:
Journal of immunotoxicology [J Immunotoxicol] 2024 Oct; Vol. 21 (sup1), pp. S13-S28. Date of Electronic Publication: 2024 Dec 10.
Autor:
Middelkamp HHT; BIOS lab-on-a-chip group, University of Twente, Enschede, the Netherlands. h.h.t.middelkamp@utwente.nl., Weener HJ; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., Gensheimer T; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., Vermeul K; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., de Heus LE; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands., Albers HJ; BIOS lab-on-a-chip group, University of Twente, Enschede, the Netherlands., van den Berg A; BIOS lab-on-a-chip group, University of Twente, Enschede, the Netherlands., van der Meer AD; Applied Stem Cell Technologies, University of Twente, Enschede, the Netherlands.
Publikováno v:
Biomedical microdevices [Biomed Microdevices] 2023 Dec 12; Vol. 26 (1), pp. 2. Date of Electronic Publication: 2023 Dec 12.
Autor:
Schneider S; Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany., Bubeck M; Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.; Institute of Biomaterials and Biomolecular Systems, University of Stuttgart, Stuttgart, Germany., Rogal J; Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.; Department of Biomedical Engineering, Faculty of Medicine, Eberhard Karls University Tübingen, Tübingen, Germany. peter.loskill@uni-tuebingen.de., Weener HJ; Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.; Applied Stem Cell Technologies, University of Twente, Enschede, The Netherlands., Rojas C; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Weiss M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Department of Women's Health, Faculty of Medicine, Eberhard Karls University Tübingen, Tübingen, Germany., Heymann M; Institute of Biomaterials and Biomolecular Systems, University of Stuttgart, Stuttgart, Germany., van der Meer AD; Applied Stem Cell Technologies, University of Twente, Enschede, The Netherlands., Loskill P; Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.; Department of Biomedical Engineering, Faculty of Medicine, Eberhard Karls University Tübingen, Tübingen, Germany. peter.loskill@uni-tuebingen.de.; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; 3R-Center for in vitro Models and Alternatives to Animal Testing, Eberhard Karls University Tübingen, Tübingen, Germany.
Publikováno v:
Lab on a chip [Lab Chip] 2021 Oct 12; Vol. 21 (20), pp. 3963-3978. Date of Electronic Publication: 2021 Oct 12.